<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>8454</number>
    <updateDate>2022-12-29T18:18:46Z</updateDate>
    <updateDateIncludingText>2022-12-29T18:18:46Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <type>HR</type>
    <introducedDate>2022-07-21</introducedDate>
    <congress>117</congress>
    <constitutionalAuthorityStatementText>
      <![CDATA[<pre>[Congressional Record Volume 168, Number 121 (Thursday, July 21, 2022)][House]From the Congressional Record Online through the Government Publishing Office [<a href="https://www.gpo.gov">www.gpo.gov</a>]By Mr. BLUMENAUER:H.R. 8454.Congress has the power to enact this legislation pursuantto the following:Article 1, Section 8, Clause 3 of the U.S. Constitution[Page H7066]</pre>]]>
    </constitutionalAuthorityStatementText>
    <committees>
      <item>
        <systemCode>hsju00</systemCode>
        <name>Judiciary Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2022-07-21T13:00:20Z</date>
          </item>
        </activities>
      </item>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred to</name>
            <date>2022-07-21T13:00:15Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <relatedBills>
      <item>
        <title>Cannabidiol and Marihuana Research Expansion Act</title>
        <congress>117</congress>
        <number>253</number>
        <type>S</type>
        <latestAction>
          <actionDate>2022-03-28</actionDate>
          <text>Message on Senate action sent to the House.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Related bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2022-12-02</actionDate>
        <text>Became Public Law No: 117-215.</text>
        <type>President</type>
        <actionCode>E40000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-12-02</actionDate>
        <text>Became Public Law No: 117-215.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-12-02</actionDate>
        <text>Signed by President.</text>
        <type>President</type>
        <actionCode>E30000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-12-02</actionDate>
        <text>Signed by President.</text>
        <type>BecameLaw</type>
        <actionCode>36000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-11-29</actionDate>
        <text>Presented to President.</text>
        <type>Floor</type>
        <actionCode>E20000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-11-29</actionDate>
        <text>Presented to President.</text>
        <type>President</type>
        <actionCode>28000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-11-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Message on Senate action sent to the House.</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2022-11-16</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Passed Senate without amendment by Voice Vote. (consideration: CR S6746-6747)</text>
        <type>Floor</type>
      </item>
      <item>
        <actionDate>2022-11-16</actionDate>
        <text>Passed/agreed to in Senate: Passed Senate without amendment by Voice Vote.</text>
        <type>Floor</type>
        <actionCode>17000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-27</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate, read twice.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>20:43:54</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>20:43:53</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 325 - 95 (Roll no. 392). (text: CR H7120-7122)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>392</rollNumber>
            <url>https://clerk.house.gov/evs/2022/roll392.xml</url>
            <chamber>House</chamber>
            <congress>117</congress>
            <date>2022-07-27T00:43:53Z</date>
            <sessionNumber>2</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>20:43:53</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by the Yeas and Nays: (2/3 required): 325 - 95 (Roll no. 392).(text: CR H7120-7122)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <recordedVotes>
          <recordedVote>
            <rollNumber>392</rollNumber>
            <url>https://clerk.house.gov/evs/2022/roll392.xml</url>
            <chamber>House</chamber>
            <congress>117</congress>
            <date>2022-07-27T00:43:53Z</date>
            <sessionNumber>2</sessionNumber>
          </recordedVote>
        </recordedVotes>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>20:34:11</actionTime>
        <text>Considered as unfinished business. (consideration: CR H7145-7146)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>17:01:56</actionTime>
        <text>At the conclusion of debate, the Yeas and Nays were demanded and ordered. Pursuant to the provisions of clause 8, rule XX, the Chair announced that further proceedings on the motion would be postponed.</text>
        <type>Floor</type>
        <actionCode>H37220</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>16:48:55</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 8454.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>16:48:54</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H7120-7124)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-26</actionDate>
        <actionTime>16:48:42</actionTime>
        <text>Mr. Pallone moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-21</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsju00</systemCode>
            <name>Judiciary Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2022-07-21</actionDate>
        <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2022-07-21</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2022-07-21</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>B000574</bioguideId>
        <fullName>Rep. Blumenauer, Earl [D-OR-3]</fullName>
        <firstName>EARL</firstName>
        <lastName>BLUMENAUER</lastName>
        <party>D</party>
        <state>OR</state>
        <identifiers>
          <bioguideId>B000574</bioguideId>
        </identifiers>
        <district>3</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>H001052</bioguideId>
        <fullName>Rep. Harris, Andy [R-MD-1]</fullName>
        <firstName>Andy</firstName>
        <lastName>Harris</lastName>
        <party>R</party>
        <state>MD</state>
        <identifiers>
          <bioguideId>H001052</bioguideId>
        </identifiers>
        <district>1</district>
        <sponsorshipDate>2022-07-21</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>G000568</bioguideId>
        <fullName>Rep. Griffith, H. Morgan [R-VA-9]</fullName>
        <firstName>H.</firstName>
        <lastName>Griffith</lastName>
        <party>R</party>
        <state>VA</state>
        <identifiers>
          <bioguideId>G000568</bioguideId>
        </identifiers>
        <middleName>Morgan</middleName>
        <district>9</district>
        <sponsorshipDate>2022-07-21</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>J000295</bioguideId>
        <fullName>Rep. Joyce, David P. [R-OH-14]</fullName>
        <firstName>David</firstName>
        <lastName>Joyce</lastName>
        <party>R</party>
        <state>OH</state>
        <identifiers>
          <bioguideId>J000295</bioguideId>
        </identifiers>
        <middleName>P.</middleName>
        <district>14</district>
        <sponsorshipDate>2022-07-21</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>N000147</bioguideId>
        <fullName>Del. Norton, Eleanor Holmes [D-DC-At Large]</fullName>
        <firstName>ELEANOR</firstName>
        <lastName>NORTON</lastName>
        <party>D</party>
        <state>DC</state>
        <identifiers>
          <bioguideId>N000147</bioguideId>
        </identifiers>
        <middleName>HOLMES</middleName>
        <district>0</district>
        <sponsorshipDate>2022-07-21</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>M000194</bioguideId>
        <fullName>Rep. Mace, Nancy [R-SC-1]</fullName>
        <firstName>Nancy</firstName>
        <lastName>Mace</lastName>
        <party>R</party>
        <state>SC</state>
        <identifiers>
          <bioguideId>M000194</bioguideId>
        </identifiers>
        <district>1</district>
        <sponsorshipDate>2022-07-21</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>P000593</bioguideId>
        <fullName>Rep. Perlmutter, Ed [D-CO-7]</fullName>
        <firstName>Ed</firstName>
        <lastName>Perlmutter</lastName>
        <party>D</party>
        <state>CO</state>
        <identifiers>
          <bioguideId>P000593</bioguideId>
        </identifiers>
        <district>7</district>
        <sponsorshipDate>2022-07-21</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>P000614</bioguideId>
        <fullName>Rep. Pappas, Chris [D-NH-1]</fullName>
        <firstName>Chris</firstName>
        <lastName>Pappas</lastName>
        <party>D</party>
        <state>NH</state>
        <identifiers>
          <bioguideId>P000614</bioguideId>
        </identifiers>
        <district>1</district>
        <sponsorshipDate>2022-07-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>L000551</bioguideId>
        <fullName>Rep. Lee, Barbara [D-CA-13]</fullName>
        <firstName>BARBARA</firstName>
        <lastName>LEE</lastName>
        <party>D</party>
        <state>CA</state>
        <identifiers>
          <bioguideId>L000551</bioguideId>
        </identifiers>
        <district>13</district>
        <sponsorshipDate>2022-07-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>D000624</bioguideId>
        <fullName>Rep. Dingell, Debbie [D-MI-12]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Dingell</lastName>
        <party>D</party>
        <state>MI</state>
        <identifiers>
          <bioguideId>D000624</bioguideId>
        </identifiers>
        <district>12</district>
        <sponsorshipDate>2022-07-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
      <item>
        <bioguideId>C001068</bioguideId>
        <fullName>Rep. Cohen, Steve [D-TN-9]</fullName>
        <firstName>Steve</firstName>
        <lastName>Cohen</lastName>
        <party>D</party>
        <state>TN</state>
        <identifiers>
          <bioguideId>C001068</bioguideId>
        </identifiers>
        <district>9</district>
        <sponsorshipDate>2022-07-22</sponsorshipDate>
        <isOriginalCosponsor>False</isOriginalCosponsor>
      </item>
    </cosponsors>
    <laws>
      <item>
        <type>Public Law</type>
        <number>117-215</number>
      </item>
    </laws>
    <policyArea>
      <name>Crime and Law Enforcement</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Alternative treatments</name>
        </item>
        <item>
          <name>Congressional oversight</name>
        </item>
        <item>
          <name>Drug safety, medical device, and laboratory regulation</name>
        </item>
        <item>
          <name>Drug therapy</name>
        </item>
        <item>
          <name>Drug trafficking and controlled substances</name>
        </item>
        <item>
          <name>Drug, alcohol, tobacco use</name>
        </item>
        <item>
          <name>Health personnel</name>
        </item>
        <item>
          <name>Licensing and registrations</name>
        </item>
        <item>
          <name>Medical research</name>
        </item>
        <item>
          <name>Public-private cooperation</name>
        </item>
        <item>
          <name>Research administration and funding</name>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Crime and Law Enforcement</name>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2022-07-21</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2022-07-27T12:01:59Z</updateDate>
        <text>
          <![CDATA[ <p><strong>Medical Marijuana and Cannabidiol Research Expansion Act</strong></p> <p>This bill establishes a new, separate registration process to facilitate research on marijuana.</p> <p>Specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.</p> <p>The bill allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the bill directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative.</p> <p>Finally, the bill includes various other provisions, including provisions that</p> <ul> <li>require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes; </li> <li>prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research; </li> <li> allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and </li> <li> require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle. </li></ul>]]>
        </text>
      </summary>
      <summary>
        <versionCode>53</versionCode>
        <actionDate>2022-07-26</actionDate>
        <actionDesc>Passed House</actionDesc>
        <updateDate>2022-08-02T13:38:49Z</updateDate>
        <text>
          <![CDATA[ <p><strong>Medical Marijuana and Cannabidiol Research Expansion Act</strong></p> <p>This bill establishes a new, separate registration process to facilitate research on marijuana.</p> <p>Specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.</p> <p>The bill allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the bill directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative.</p> <p>Finally, the bill includes various other provisions, including provisions that</p> <ul> <li>require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes; </li> <li>prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research; </li> <li> allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and </li> <li> require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle. </li></ul>]]>
        </text>
      </summary>
      <summary>
        <versionCode>55</versionCode>
        <actionDate>2022-11-16</actionDate>
        <actionDesc>Passed Senate</actionDesc>
        <updateDate>2022-11-29T16:23:41Z</updateDate>
        <text>
          <![CDATA[ <p><strong>Medical Marijuana and Cannabidiol Research Expansion Act</strong></p> <p>This bill establishes a new, separate registration process to facilitate research on marijuana.</p> <p>Specifically, the bill directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.</p> <p>The bill allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the bill directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative.</p> <p>Finally, the bill includes various other provisions, including provisions that</p> <ul> <li>require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes; </li> <li>prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research; </li> <li> allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and </li> <li> require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle. </li></ul>]]>
        </text>
      </summary>
      <summary>
        <versionCode>49</versionCode>
        <actionDate>2022-12-02</actionDate>
        <actionDesc>Public Law</actionDesc>
        <updateDate>2022-12-20T15:26:13Z</updateDate>
        <text>
          <![CDATA[ <p><strong>Medical Marijuana and Cannabidiol Research Expansion Act</strong></p> <p>This act establishes a new, separate registration process to facilitate research on marijuana.</p> <p>Specifically, the act directs the Drug Enforcement Administration (DEA) to follow specified procedures to register (1) practitioners to conduct marijuana research, and (2) manufacturers to supply marijuana for the research.</p> <p>The act allows certain registered entities (including institutions of higher education, practitioners, and manufacturers) to manufacture, distribute, dispense, or possess marijuana or cannabidiol (CBD) for the purposes of medical research. Additionally, the act directs the DEA to register manufacturers and distributors of CBD or marijuana for the purpose of commercial production of an approved drug that contains marijuana or its derivative.</p> <p>Finally, the act includes various other provisions, including provisions that</p> <ul> <li>require the DEA to assess whether there is an adequate and uninterrupted supply of marijuana for research purposes; </li> <li>prohibit the Department of Health and Human Services (HHS) from reinstating the interdisciplinary review process for marijuana research; </li> <li> allow physicians to discuss the potential harms and benefits of marijuana and its derivatives (including CBD) with patients; and </li> <li> require HHS, in coordination with the National Institutes of Health and relevant federal agencies, to report on the therapeutic potential of marijuana for various conditions such as epilepsy, as well as the impact on adolescent brains and on the ability to operate a motor vehicle. </li></ul>]]>
        </text>
      </summary>
    </summaries>
    <title>Medical Marijuana and Cannabidiol Research Expansion Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <title>Medical Marijuana and Cannabidiol Research Expansion Act</title>
      </item>
      <item>
        <titleType>Short Titles as Enacted</titleType>
        <title>Medical Marijuana and Cannabidiol Research Expansion Act</title>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <title>To expand research on cannabidiol and marijuana, and for other purposes.</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Titles as Passed Senate</titleType>
        <title>Medical Marijuana and Cannabidiol Research Expansion Act</title>
        <chamberCode>S</chamberCode>
        <chamberName>Senate</chamberName>
      </item>
      <item>
        <titleType>Short Title(s) as Passed House</titleType>
        <title>Medical Marijuana and Cannabidiol Research Expansion Act</title>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <title>Medical Marijuana and Cannabidiol Research Expansion Act</title>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Enrolled Bill</type>
        <date/>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr8454enr/xml/BILLS-117hr8454enr.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Engrossed in House</type>
        <date>2022-07-26T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr8454eh/xml/BILLS-117hr8454eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2022-07-21T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-117hr8454ih/xml/BILLS-117hr8454ih.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <date>2022-12-03T04:59:59Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/PLAW-117publ215_uslm/xml/PLAW-117publ215_uslm.xml</url>
          </item>
        </formats>
        <type>Public Law</type>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2022-12-02</actionDate>
      <text>Became Public Law No: 117-215.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
